Comparative study of the impact of adjuvant trastuzumab and its biosimilars on cardiac function in HER2-positive early breast cancer patients: a single-center study.

Saved in:
Bibliographic Details
Title: Comparative study of the impact of adjuvant trastuzumab and its biosimilars on cardiac function in HER2-positive early breast cancer patients: a single-center study.
Authors: Au LSJ; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong SAR, China., Luk MY; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong SAR, China., Lee VHF; Department of Clinical Oncology, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China., Yuen KK; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong SAR, China.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 22; Vol. 15, pp. 1673372. Date of Electronic Publication: 2025 Oct 22 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1673372